Clinical trials
Completed Dwarfism, Pituitary trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
162 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 5 |
| 2002 | 5 |
| 2003 | 14 |
| 2004 | 11 |
| 2005 | 12 |
| 2006 | 6 |
| 2007 | 12 |
| 2008 | 8 |
| 2009 | 8 |
| 2010 | 9 |
| 2011 | 8 |
| 2012 | 3 |
| 2013 | 6 |
| 2014 | 6 |
| 2015 | 8 |
| 2016 | 4 |
| 2017 | 7 |
| 2018 | 3 |
| 2019 | 6 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 162 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 23 |
| Merck KGaA, Darmstadt, Germany | 9 |
| Pfizer | 9 |
| Federico II University | 6 |
| Massachusetts General Hospital | 5 |
| Ascendis Pharma Endocrinology Division A/S | 4 |
| Eli Lilly and Company | 4 |
| LG Life Sciences | 4 |
| OPKO Health, Inc. | 4 |
| University of Aarhus | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dwarfism, Pituitary | 162 |
| Dwarfism | 11 |
| Pituitary Diseases | 9 |
| Endocrine System Diseases | 8 |
| Hypopituitarism | 7 |
| Insulin Resistance | 7 |
| Turner Syndrome | 7 |
| Failure to Thrive | 6 |
| Acromegaly | 5 |
| Kidney Failure, Chronic | 4 |
Trials
Showing 26 to 50 of 162. Each trial links to its page on Pharma Observatory.
62 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.